Form 4 for INDV Indivior Pharmaceuticals, Inc.
Accepted 2026-08-05 16:52:07 ET · period of report 2026-08-05 · accession 0002014440-26-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 16:52 | 2026-08-05 | INDV | Anderson Woodrow D | CAO | P - Purchase | $36.28 | +1,500 | 26.1K | +6% | +$54.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-05 | P | A | 1,500 | $36.28 | 26,138 | D | — | — |